How TransMedics is reviving technology for surgery technicians

By Admin
New technology created by TransMedics can mimic the conditions of the human body and may help replenish the low supply of hearts for transplantation by...

New technology created by TransMedics can mimic the conditions of the human body and may help replenish the low supply of hearts for transplantation by as much as 30 percent.

Called Organ Care System (OCS) maintains organs in a warm, functioning state outside of the body rather than the traditional method of keeping organs on ice until reaching a recipient.

Click here to read the latest edition of Healthcare Global magazine!

As reported by our sister publication Business Review Australia, the portable machine has already been used in 15 successful heart transplants in Australia and the United Kingdom and has recently been approved for medical use in the U.S.

Earlier this year, surgeons at St. Vincent’s Hospital in New South Wales discussed three cases where they waited as little as two minutes after a person’s heart stopped before removing it. They then attached it to the OCS within 20 minutes and it began beating once again.

RELATED TOPIC: AT&T, Permobil expand IoT concepts with connected wheelchair

“OCS, a AUD$250,000 device, essentially consists of a sterile chamber containing oxygen, blood and nutrient supply to the heart,” wrote Business Review Australia, “which keeps the heart pumping outside of the human body until it is ready for transplant.”

The “living” organ transplant increases the amount of time an organ can be maintained outside of the body, giving surgeons a chance to assess the function of the organ and allow resuscitation of the organ once removed from the deceased owner.

RELATED TOPIC: How surgical hospitals can expand in 2016 via technology

“The device is vital,” said Stephen Large, a surgeon at the UK’s Papworth Hospital, which has used OCS as part of eight different transplants. “The heart gets an absolutely essential infusion of blood to restore its energy.”

Let's connect!   

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare